Vyriad
Rochester
About Vyriad
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the treatment of cancers with significant unmet needs. The potentially life-changing oncolytic viral technologies of Vyriad are the result of decades of research by dedicated researchers and clinicians at Mayo Clinic and the University of Miami.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $88.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2025)
- Website: vyriad.com
- Phone: 507-289-0944
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/vyriad-58735 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.